CMRX(Delisted)
ChimerixยทNASDAQ
--
--(--)
CMRX Profile
Chimerix, Inc.
A company that developing oral antiviral therapeutics for the prevention of cytomegalovirus infection
2505 Meridian Parkway
, Suite 100
, Durham
, North Carolina 27713
--
Chimerix, Inc., was incorporated in Delaware in April 2000. Chimerix is a biopharmaceutical company whose mission is to develop drugs that meaningfully improve and prolong the lives of patients facing deadly diseases. The company is focused on developing pyridone as a potential new selective cancer therapy. At present, the most advanced disopyrum is ONC 201, and its main indication is the clinical development stage of H 3 K 27 M mutant glioma. In addition, disopyrone ONC 206 is currently undergoing dose-escalation clinical trials.
